Saniona AB: Sanionas partner, Medix, avslutar rekrytering till Fas 3-studie med tesofensine på fetma i Mexiko
February 01, 2018 02:01 ET
|
Saniona AB
PRESSMEDDELANDE 1 februari 2018 Saniona, ett ledande bioteknikföretag inom jonkanaler, meddelar idag att bolagets partner i Mexiko, Medix, har avslutat rekrytering till sin kliniska Fas 3-studie...
Saniona AB: Saniona's Partner, Medix, Completes Recruitment of Phase 3 Obesity Study of Tesofensine in Mexico
February 01, 2018 02:01 ET
|
Saniona AB
PRESS RELEASE February 1, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that its partner in Mexico, Medix, has completed recruitment for its Phase 3...
Saniona AB: Saniona och Proximagen förlänger forskningssamarbete
January 26, 2018 02:01 ET
|
Saniona AB
PRESSMEDDELANDE 26 januari 2018 Saniona, ett ledande bioteknikföretag inom jonkanaler, meddelar idag att Saniona och Proximagen har inleder lead optimization-arbete in sitt pågående forsknings-...
Saniona AB: Saniona and Proximagen extend research collaboration
January 26, 2018 02:01 ET
|
Saniona AB
PRESS RELEASE January 26, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that Saniona and Proximagen have initiated lead optimization in their ongoing drug...
Saniona AB: Kommuniké från extra bolagsstämma den 19 januari 2018 i Saniona AB
January 19, 2018 06:01 ET
|
Saniona AB
PRESSMEDDELANDE 19 januari 2018 Idag, den 19 januari 2018, hölls extra bolagsstämma i Saniona AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga beslut fattades med...
Saniona AB: Bulletin from the extraordinary shareholders' meeting on January 19, 2018 in Saniona AB
January 19, 2018 06:01 ET
|
Saniona AB
PRESS RELEASE January 19, 2018 Today, on January 19, 2018, an extraordinary shareholders' meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions...
Saniona AB: Saniona inleder Fas 1-studie med ny Tesomettablett
January 16, 2018 07:20 ET
|
Saniona AB
PRESSMEDDELANDE 16 januari 2018 Saniona, ett ledande bioteknikbolag inom jonkanaler, meddelar idag att bolaget har doserat de första 10 deltagarna i en farmakokinetisk fas 1-studie med den nya...
Saniona AB: Saniona initiates Phase I study with new Tesomet tablet
January 16, 2018 07:20 ET
|
Saniona AB
PRESS RELEASE January 16, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has dosed the first 10 participants in a Phase 1 pharmacokinetic study of...
Saniona AB: Saniona rapporterar topplinjeresultat från Tesomet Fas 2a interimstudien i Prader-Willis syndrom
January 08, 2018 02:01 ET
|
Saniona AB
PRESSMEDDELANDE 8 januari 2018 Saniona, ett ledande bioteknikföretag inom jonkanaler, meddelar idag topplinjeresultat från sin undersökande fas 2a kliniska studie för Tesomet i patienter med...
Saniona AB: Saniona reports top line results from the Tesomet Phase 2a interim study in Prader-Willi syndrome
January 08, 2018 02:01 ET
|
Saniona AB
PRESS RELEASE January 8, 2018 Saniona, a leading biotech company in the field of ion channels, today announced top line results from its exploratory Phase 2a clinical trial for Tesomet in patients...